nodes	percent_of_prediction	percent_of_DWPC	metapath
Probenecid—CYP2C19—coronary artery disease	0.0941	0.643	CbGaD
Probenecid—SLC2A9—Losartan—coronary artery disease	0.0728	0.115	CbGbCtD
Probenecid—SLC22A12—Losartan—coronary artery disease	0.0526	0.0831	CbGbCtD
Probenecid—ALB—coronary artery disease	0.0522	0.357	CbGaD
Probenecid—SLC10A1—Pitavastatin—coronary artery disease	0.0311	0.049	CbGbCtD
Probenecid—SLC16A1—Niacin—coronary artery disease	0.0238	0.0376	CbGbCtD
Probenecid—SLC16A1—Pravastatin—coronary artery disease	0.0184	0.0291	CbGbCtD
Probenecid—ABCC5—Atorvastatin—coronary artery disease	0.0168	0.0265	CbGbCtD
Probenecid—SLC22A7—Enalapril—coronary artery disease	0.0128	0.0202	CbGbCtD
Probenecid—ABCC3—Ezetimibe—coronary artery disease	0.0127	0.0201	CbGbCtD
Probenecid—ABCC2—Olmesartan—coronary artery disease	0.00981	0.0155	CbGbCtD
Probenecid—ABCC4—Rosuvastatin—coronary artery disease	0.00972	0.0154	CbGbCtD
Probenecid—SLC22A7—Acetylsalicylic acid—coronary artery disease	0.0097	0.0153	CbGbCtD
Probenecid—SLC22A11—Pravastatin—coronary artery disease	0.0095	0.015	CbGbCtD
Probenecid—SLC22A7—Pravastatin—coronary artery disease	0.00905	0.0143	CbGbCtD
Probenecid—SLCO1A2—Enalapril—coronary artery disease	0.00897	0.0142	CbGbCtD
Probenecid—SLC22A5—Niacin—coronary artery disease	0.00874	0.0138	CbGbCtD
Probenecid—SLC22A11—Furosemide—coronary artery disease	0.00808	0.0128	CbGbCtD
Probenecid—ABCC4—Atorvastatin—coronary artery disease	0.00806	0.0127	CbGbCtD
Probenecid—ABCC2—Pitavastatin—coronary artery disease	0.00785	0.0124	CbGbCtD
Probenecid—ABCC2—Telmisartan—coronary artery disease	0.00785	0.0124	CbGbCtD
Probenecid—ABCC1—Rosuvastatin—coronary artery disease	0.00781	0.0123	CbGbCtD
Probenecid—SLC22A8—Enalapril—coronary artery disease	0.00781	0.0123	CbGbCtD
Probenecid—SLCO1A2—Rosuvastatin—coronary artery disease	0.00698	0.011	CbGbCtD
Probenecid—SLCO1A2—Simvastatin—coronary artery disease	0.00649	0.0102	CbGbCtD
Probenecid—ABCC1—Atorvastatin—coronary artery disease	0.00648	0.0102	CbGbCtD
Probenecid—SLCO1A2—Lovastatin—coronary artery disease	0.00635	0.01	CbGbCtD
Probenecid—SLCO1A2—Pravastatin—coronary artery disease	0.00635	0.01	CbGbCtD
Probenecid—CYP2C8—Fenofibrate—coronary artery disease	0.00624	0.00985	CbGbCtD
Probenecid—ABCC2—Ezetimibe—coronary artery disease	0.00578	0.00913	CbGbCtD
Probenecid—SLCO1A2—Atorvastatin—coronary artery disease	0.00578	0.00913	CbGbCtD
Probenecid—SLC22A5—Furosemide—coronary artery disease	0.00575	0.00908	CbGbCtD
Probenecid—SLC22A8—Pravastatin—coronary artery disease	0.00553	0.00873	CbGbCtD
Probenecid—SLC22A6—Enalapril—coronary artery disease	0.00544	0.00859	CbGbCtD
Probenecid—ABCC2—Simvastatin—coronary artery disease	0.00538	0.00849	CbGbCtD
Probenecid—ABCC2—Pravastatin—coronary artery disease	0.00526	0.00831	CbGbCtD
Probenecid—ABCC2—Lovastatin—coronary artery disease	0.00526	0.00831	CbGbCtD
Probenecid—CYP2C8—Gemfibrozil—coronary artery disease	0.00499	0.00787	CbGbCtD
Probenecid—ALB—Pitavastatin—coronary artery disease	0.00489	0.00772	CbGbCtD
Probenecid—ABCC2—Atorvastatin—coronary artery disease	0.00479	0.00757	CbGbCtD
Probenecid—ALB—Valsartan—coronary artery disease	0.00476	0.00751	CbGbCtD
Probenecid—ABCB1—Ticagrelor—coronary artery disease	0.00474	0.00748	CbGbCtD
Probenecid—SLC22A8—Furosemide—coronary artery disease	0.0047	0.00742	CbGbCtD
Probenecid—ABCC2—Furosemide—coronary artery disease	0.00447	0.00707	CbGbCtD
Probenecid—CYP2C9—Fenofibrate—coronary artery disease	0.00435	0.00687	CbGbCtD
Probenecid—CYP2C8—Clopidogrel—coronary artery disease	0.00432	0.00683	CbGbCtD
Probenecid—CYP2C19—Gemfibrozil—coronary artery disease	0.00418	0.00661	CbGbCtD
Probenecid—SLC22A6—Acetylsalicylic acid—coronary artery disease	0.00412	0.00651	CbGbCtD
Probenecid—SLC22A6—Captopril—coronary artery disease	0.00407	0.00643	CbGbCtD
Probenecid—SLC22A6—Pravastatin—coronary artery disease	0.00385	0.00608	CbGbCtD
Probenecid—CYP2C8—Pitavastatin—coronary artery disease	0.00378	0.00597	CbGbCtD
Probenecid—CYP2C19—Clopidogrel—coronary artery disease	0.00363	0.00573	CbGbCtD
Probenecid—ALB—Rosuvastatin—coronary artery disease	0.0036	0.00569	CbGbCtD
Probenecid—ALB—Acetylsalicylic acid—coronary artery disease	0.00351	0.00555	CbGbCtD
Probenecid—CYP2C9—Gemfibrozil—coronary artery disease	0.00348	0.00549	CbGbCtD
Probenecid—ALB—Captopril—coronary artery disease	0.00347	0.00548	CbGbCtD
Probenecid—CYP2C9—cardial valve—coronary artery disease	0.00337	0.141	CbGeAlD
Probenecid—SLC22A6—Furosemide—coronary artery disease	0.00327	0.00517	CbGbCtD
Probenecid—SLC22A6—Losartan—coronary artery disease	0.00321	0.00507	CbGbCtD
Probenecid—CYP2C19—Telmisartan—coronary artery disease	0.00317	0.00501	CbGbCtD
Probenecid—CYP2C9—Clopidogrel—coronary artery disease	0.00302	0.00476	CbGbCtD
Probenecid—ABCB1—Perindopril—coronary artery disease	0.00293	0.00462	CbGbCtD
Probenecid—ABCB1—Clopidogrel—coronary artery disease	0.00293	0.00462	CbGbCtD
Probenecid—CYP3A4—Ticagrelor—coronary artery disease	0.00284	0.00448	CbGbCtD
Probenecid—ALB—Furosemide—coronary artery disease	0.00279	0.0044	CbGbCtD
Probenecid—ALB—Losartan—coronary artery disease	0.00273	0.00431	CbGbCtD
Probenecid—CYP2C8—Acetylsalicylic acid—coronary artery disease	0.00271	0.00429	CbGbCtD
Probenecid—CYP2C9—Pitavastatin—coronary artery disease	0.00264	0.00416	CbGbCtD
Probenecid—CYP2C8—Simvastatin—coronary artery disease	0.00259	0.00409	CbGbCtD
Probenecid—CYP2C9—Valsartan—coronary artery disease	0.00256	0.00405	CbGbCtD
Probenecid—ABCB1—Pitavastatin—coronary artery disease	0.00256	0.00404	CbGbCtD
Probenecid—ABCB1—Telmisartan—coronary artery disease	0.00256	0.00404	CbGbCtD
Probenecid—CYP2C19—Timolol—coronary artery disease	0.00256	0.00403	CbGbCtD
Probenecid—CYP2C8—Lovastatin—coronary artery disease	0.00253	0.004	CbGbCtD
Probenecid—CYP2C8—Pravastatin—coronary artery disease	0.00253	0.004	CbGbCtD
Probenecid—CYP3A4—Fenofibrate—coronary artery disease	0.00253	0.00399	CbGbCtD
Probenecid—ABCB1—Enalapril—coronary artery disease	0.00242	0.00383	CbGbCtD
Probenecid—ABCB1—Lisinopril—coronary artery disease	0.00242	0.00383	CbGbCtD
Probenecid—CYP2C19—Rosuvastatin—coronary artery disease	0.00234	0.00369	CbGbCtD
Probenecid—CYP2C8—Atorvastatin—coronary artery disease	0.00231	0.00365	CbGbCtD
Probenecid—CYP2C19—Acetylsalicylic acid—coronary artery disease	0.00228	0.0036	CbGbCtD
Probenecid—CYP2C19—Simvastatin—coronary artery disease	0.00217	0.00343	CbGbCtD
Probenecid—CYP2C19—Lovastatin—coronary artery disease	0.00213	0.00336	CbGbCtD
Probenecid—CYP2C8—Losartan—coronary artery disease	0.00211	0.00333	CbGbCtD
Probenecid—ABCB1—Timolol—coronary artery disease	0.00206	0.00326	CbGbCtD
Probenecid—CYP3A4—Gemfibrozil—coronary artery disease	0.00202	0.00319	CbGbCtD
Probenecid—CYP2C9—Rosuvastatin—coronary artery disease	0.00194	0.00307	CbGbCtD
Probenecid—CYP2C19—Atorvastatin—coronary artery disease	0.00194	0.00306	CbGbCtD
Probenecid—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.00189	0.00299	CbGbCtD
Probenecid—ABCB1—Ezetimibe—coronary artery disease	0.00189	0.00298	CbGbCtD
Probenecid—ABCB1—Acetylsalicylic acid—coronary artery disease	0.00184	0.0029	CbGbCtD
Probenecid—ABCB1—Captopril—coronary artery disease	0.00182	0.00287	CbGbCtD
Probenecid—CYP2C9—Simvastatin—coronary artery disease	0.00181	0.00285	CbGbCtD
Probenecid—CYP2C19—Losartan—coronary artery disease	0.00177	0.0028	CbGbCtD
Probenecid—CYP2C9—Lovastatin—coronary artery disease	0.00177	0.00279	CbGbCtD
Probenecid—CYP2C9—Pravastatin—coronary artery disease	0.00177	0.00279	CbGbCtD
Probenecid—CYP3A4—Clopidogrel—coronary artery disease	0.00175	0.00277	CbGbCtD
Probenecid—ABCB1—Simvastatin—coronary artery disease	0.00175	0.00277	CbGbCtD
Probenecid—ABCB1—Lovastatin—coronary artery disease	0.00172	0.00271	CbGbCtD
Probenecid—ABCB1—Pravastatin—coronary artery disease	0.00172	0.00271	CbGbCtD
Probenecid—CYP3A4—Eplerenone—coronary artery disease	0.00163	0.00257	CbGbCtD
Probenecid—CYP2C9—Atorvastatin—coronary artery disease	0.00161	0.00254	CbGbCtD
Probenecid—PANX1—myocardium—coronary artery disease	0.0016	0.0666	CbGeAlD
Probenecid—ABCB1—Atorvastatin—coronary artery disease	0.00156	0.00247	CbGbCtD
Probenecid—CYP2C9—Losartan—coronary artery disease	0.00147	0.00233	CbGbCtD
Probenecid—CYP3A4—Enalapril—coronary artery disease	0.00145	0.00229	CbGbCtD
Probenecid—ABCB1—Losartan—coronary artery disease	0.00143	0.00226	CbGbCtD
Probenecid—CYP3A4—Ezetimibe—coronary artery disease	0.00113	0.00178	CbGbCtD
Probenecid—CYP3A4—Rosuvastatin—coronary artery disease	0.00113	0.00178	CbGbCtD
Probenecid—PANX1—heart—coronary artery disease	0.00111	0.0465	CbGeAlD
Probenecid—PANX1—cardiovascular system—coronary artery disease	0.00105	0.0439	CbGeAlD
Probenecid—CYP3A4—Simvastatin—coronary artery disease	0.00105	0.00166	CbGbCtD
Probenecid—CYP3A4—Pravastatin—coronary artery disease	0.00103	0.00162	CbGbCtD
Probenecid—CYP3A4—Lovastatin—coronary artery disease	0.00103	0.00162	CbGbCtD
Probenecid—SLC2A9—heart—coronary artery disease	0.00101	0.0422	CbGeAlD
Probenecid—CYP3A4—Atorvastatin—coronary artery disease	0.000936	0.00148	CbGbCtD
Probenecid—SLC16A7—cardiac ventricle—coronary artery disease	0.000908	0.0379	CbGeAlD
Probenecid—CYP3A4—Losartan—coronary artery disease	0.000856	0.00135	CbGbCtD
Probenecid—SLC16A7—myocardium—coronary artery disease	0.000854	0.0356	CbGeAlD
Probenecid—PANX1—blood—coronary artery disease	0.000831	0.0347	CbGeAlD
Probenecid—SLC2A9—blood—coronary artery disease	0.000754	0.0315	CbGeAlD
Probenecid—ABCC5—cardiac ventricle—coronary artery disease	0.000635	0.0265	CbGeAlD
Probenecid—ABCC5—myocardium—coronary artery disease	0.000597	0.0249	CbGeAlD
Probenecid—SLC16A7—heart—coronary artery disease	0.000596	0.0249	CbGeAlD
Probenecid—ABCC6—cardiovascular system—coronary artery disease	0.000579	0.0242	CbGeAlD
Probenecid—SLC16A1—cardiac ventricle—coronary artery disease	0.000578	0.0241	CbGeAlD
Probenecid—SLC16A7—cardiovascular system—coronary artery disease	0.000562	0.0235	CbGeAlD
Probenecid—SLC16A1—myocardium—coronary artery disease	0.000543	0.0227	CbGeAlD
Probenecid—SLC16A7—cardiac atrium—coronary artery disease	0.00051	0.0213	CbGeAlD
Probenecid—ABCC6—blood—coronary artery disease	0.000458	0.0191	CbGeAlD
Probenecid—SLC16A7—blood—coronary artery disease	0.000445	0.0186	CbGeAlD
Probenecid—ABCC5—heart—coronary artery disease	0.000417	0.0174	CbGeAlD
Probenecid—SLC16A1—heart—coronary artery disease	0.000379	0.0158	CbGeAlD
Probenecid—SLC16A1—cardiovascular system—coronary artery disease	0.000358	0.0149	CbGeAlD
Probenecid—ABCC5—cardiac atrium—coronary artery disease	0.000357	0.0149	CbGeAlD
Probenecid—ABCC1—myocardium—coronary artery disease	0.000353	0.0147	CbGeAlD
Probenecid—Procainamide—SLC22A3—coronary artery disease	0.000337	0.45	CrCbGaD
Probenecid—SLC22A5—cardiac ventricle—coronary artery disease	0.00033	0.0138	CbGeAlD
Probenecid—SLC16A1—cardiac atrium—coronary artery disease	0.000324	0.0135	CbGeAlD
Probenecid—SLC22A5—myocardium—coronary artery disease	0.00031	0.013	CbGeAlD
Probenecid—ALB—heart—coronary artery disease	0.000299	0.0125	CbGeAlD
Probenecid—ABCC4—heart—coronary artery disease	0.000289	0.0121	CbGeAlD
Probenecid—ABCC3—blood—coronary artery disease	0.000261	0.0109	CbGeAlD
Probenecid—ABCC1—heart—coronary artery disease	0.000246	0.0103	CbGeAlD
Probenecid—SLC22A1—blood—coronary artery disease	0.000233	0.00971	CbGeAlD
Probenecid—SLC22A5—heart—coronary artery disease	0.000217	0.00905	CbGeAlD
Probenecid—ABCC4—blood—coronary artery disease	0.000216	0.009	CbGeAlD
Probenecid—SLC22A8—blood—coronary artery disease	0.000214	0.00893	CbGeAlD
Probenecid—ABCC1—cardiac atrium—coronary artery disease	0.000211	0.0088	CbGeAlD
Probenecid—Chlorpropamide—CYP2C19—coronary artery disease	0.000209	0.279	CrCbGaD
Probenecid—ABCC2—blood—coronary artery disease	0.000209	0.00871	CbGeAlD
Probenecid—Tolbutamide—CYP2C19—coronary artery disease	0.000204	0.272	CrCbGaD
Probenecid—Leukopenia—Perindopril—coronary artery disease	0.000196	0.002	CcSEcCtD
Probenecid—Pruritus—Rosuvastatin—coronary artery disease	0.000196	0.002	CcSEcCtD
Probenecid—Vomiting—Ticagrelor—coronary artery disease	0.000196	0.002	CcSEcCtD
Probenecid—Haematuria—Lisinopril—coronary artery disease	0.000195	0.00199	CcSEcCtD
Probenecid—Dermatitis—Ticagrelor—coronary artery disease	0.000194	0.00198	CcSEcCtD
Probenecid—Headache—Ticagrelor—coronary artery disease	0.000193	0.00197	CcSEcCtD
Probenecid—Pain—Eplerenone—coronary artery disease	0.000193	0.00197	CcSEcCtD
Probenecid—Anorexia—Niacin—coronary artery disease	0.000192	0.00196	CcSEcCtD
Probenecid—Anaphylactic shock—Enalapril—coronary artery disease	0.000192	0.00196	CcSEcCtD
Probenecid—Erythema multiforme—Ramipril—coronary artery disease	0.000192	0.00195	CcSEcCtD
Probenecid—Urticaria—Fenofibrate—coronary artery disease	0.000191	0.00195	CcSEcCtD
Probenecid—Decreased appetite—Simvastatin—coronary artery disease	0.000191	0.00195	CcSEcCtD
Probenecid—Leukopenia—Furosemide—coronary artery disease	0.000191	0.00195	CcSEcCtD
Probenecid—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000191	0.00194	CcSEcCtD
Probenecid—Body temperature increased—Fenofibrate—coronary artery disease	0.00019	0.00194	CcSEcCtD
Probenecid—Anaemia—Losartan—coronary artery disease	0.00019	0.00194	CcSEcCtD
Probenecid—Anaphylactic shock—Telmisartan—coronary artery disease	0.00019	0.00193	CcSEcCtD
Probenecid—Anorexia—Pravastatin—coronary artery disease	0.000189	0.00193	CcSEcCtD
Probenecid—Flushing—Ramipril—coronary artery disease	0.000188	0.00192	CcSEcCtD
Probenecid—Pain—Simvastatin—coronary artery disease	0.000188	0.00192	CcSEcCtD
Probenecid—Urticaria—Clopidogrel—coronary artery disease	0.000188	0.00192	CcSEcCtD
Probenecid—Nausea—Gemfibrozil—coronary artery disease	0.000187	0.00191	CcSEcCtD
Probenecid—Body temperature increased—Clopidogrel—coronary artery disease	0.000187	0.00191	CcSEcCtD
Probenecid—Urticaria—Lovastatin—coronary artery disease	0.000187	0.0019	CcSEcCtD
Probenecid—CYP2C9—heart—coronary artery disease	0.000186	0.00778	CbGeAlD
Probenecid—Body temperature increased—Lovastatin—coronary artery disease	0.000186	0.00189	CcSEcCtD
Probenecid—SLC22A5—cardiac atrium—coronary artery disease	0.000185	0.00774	CbGeAlD
Probenecid—Anaphylactic shock—Captopril—coronary artery disease	0.000184	0.00188	CcSEcCtD
Probenecid—Leukopenia—Losartan—coronary artery disease	0.000184	0.00188	CcSEcCtD
Probenecid—Anorexia—Trandolapril—coronary artery disease	0.000184	0.00188	CcSEcCtD
Probenecid—ABCC1—blood—coronary artery disease	0.000184	0.00768	CbGeAlD
Probenecid—Dizziness—Rosuvastatin—coronary artery disease	0.000183	0.00187	CcSEcCtD
Probenecid—Anorexia—Enalapril—coronary artery disease	0.000183	0.00187	CcSEcCtD
Probenecid—Urticaria—Ezetimibe—coronary artery disease	0.000183	0.00187	CcSEcCtD
Probenecid—Nausea—Ticagrelor—coronary artery disease	0.000183	0.00187	CcSEcCtD
Probenecid—Body temperature increased—Ezetimibe—coronary artery disease	0.000182	0.00186	CcSEcCtD
Probenecid—Anorexia—Telmisartan—coronary artery disease	0.000181	0.00184	CcSEcCtD
Probenecid—Decreased appetite—Valsartan—coronary artery disease	0.000181	0.00184	CcSEcCtD
Probenecid—Decreased appetite—Olmesartan—coronary artery disease	0.00018	0.00183	CcSEcCtD
Probenecid—CYP2C19—blood—coronary artery disease	0.000179	0.00749	CbGeAlD
Probenecid—Alopecia—Ramipril—coronary artery disease	0.000179	0.00183	CcSEcCtD
Probenecid—Anaphylactic shock—Perindopril—coronary artery disease	0.000179	0.00182	CcSEcCtD
Probenecid—Body temperature increased—Eplerenone—coronary artery disease	0.000178	0.00182	CcSEcCtD
Probenecid—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000178	0.00182	CcSEcCtD
Probenecid—Hypersensitivity—Fenofibrate—coronary artery disease	0.000177	0.00181	CcSEcCtD
Probenecid—Pain—Olmesartan—coronary artery disease	0.000177	0.0018	CcSEcCtD
Probenecid—CYP2C9—cardiovascular system—coronary artery disease	0.000176	0.00734	CbGeAlD
Probenecid—Anorexia—Captopril—coronary artery disease	0.000176	0.00179	CcSEcCtD
Probenecid—Decreased appetite—Niacin—coronary artery disease	0.000176	0.00179	CcSEcCtD
Probenecid—Alopecia—Timolol—coronary artery disease	0.000175	0.00178	CcSEcCtD
Probenecid—Dermatitis—Rosuvastatin—coronary artery disease	0.000175	0.00178	CcSEcCtD
Probenecid—Urticaria—Simvastatin—coronary artery disease	0.000175	0.00178	CcSEcCtD
Probenecid—Hypersensitivity—Clopidogrel—coronary artery disease	0.000174	0.00178	CcSEcCtD
Probenecid—Anaphylactic shock—Furosemide—coronary artery disease	0.000174	0.00177	CcSEcCtD
Probenecid—Body temperature increased—Simvastatin—coronary artery disease	0.000174	0.00177	CcSEcCtD
Probenecid—Erythema multiforme—Lisinopril—coronary artery disease	0.000174	0.00177	CcSEcCtD
Probenecid—Headache—Rosuvastatin—coronary artery disease	0.000174	0.00177	CcSEcCtD
Probenecid—Hypersensitivity—Lovastatin—coronary artery disease	0.000173	0.00176	CcSEcCtD
Probenecid—Decreased appetite—Pravastatin—coronary artery disease	0.000173	0.00176	CcSEcCtD
Probenecid—Pain—Niacin—coronary artery disease	0.000173	0.00176	CcSEcCtD
Probenecid—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000171	0.00175	CcSEcCtD
Probenecid—Anorexia—Perindopril—coronary artery disease	0.000171	0.00174	CcSEcCtD
Probenecid—Flushing—Lisinopril—coronary artery disease	0.000171	0.00174	CcSEcCtD
Probenecid—Pruritus—Fenofibrate—coronary artery disease	0.00017	0.00174	CcSEcCtD
Probenecid—Pain—Pravastatin—coronary artery disease	0.00017	0.00173	CcSEcCtD
Probenecid—Hypersensitivity—Ezetimibe—coronary artery disease	0.00017	0.00173	CcSEcCtD
Probenecid—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.00017	0.00173	CcSEcCtD
Probenecid—Anaphylactic shock—Losartan—coronary artery disease	0.000168	0.00171	CcSEcCtD
Probenecid—Decreased appetite—Trandolapril—coronary artery disease	0.000168	0.00171	CcSEcCtD
Probenecid—Pruritus—Clopidogrel—coronary artery disease	0.000167	0.00171	CcSEcCtD
Probenecid—Decreased appetite—Enalapril—coronary artery disease	0.000167	0.0017	CcSEcCtD
Probenecid—Pruritus—Lovastatin—coronary artery disease	0.000166	0.00169	CcSEcCtD
Probenecid—Anorexia—Furosemide—coronary artery disease	0.000166	0.00169	CcSEcCtD
Probenecid—Urticaria—Valsartan—coronary artery disease	0.000165	0.00168	CcSEcCtD
Probenecid—Decreased appetite—Telmisartan—coronary artery disease	0.000165	0.00168	CcSEcCtD
Probenecid—Nausea—Rosuvastatin—coronary artery disease	0.000165	0.00168	CcSEcCtD
Probenecid—Urticaria—Olmesartan—coronary artery disease	0.000164	0.00167	CcSEcCtD
Probenecid—Body temperature increased—Olmesartan—coronary artery disease	0.000163	0.00166	CcSEcCtD
Probenecid—Pruritus—Ezetimibe—coronary artery disease	0.000163	0.00166	CcSEcCtD
Probenecid—Alopecia—Lisinopril—coronary artery disease	0.000162	0.00166	CcSEcCtD
Probenecid—Pain—Telmisartan—coronary artery disease	0.000162	0.00165	CcSEcCtD
Probenecid—Hypersensitivity—Simvastatin—coronary artery disease	0.000162	0.00165	CcSEcCtD
Probenecid—SLC22A5—blood—coronary artery disease	0.000162	0.00675	CbGeAlD
Probenecid—Urticaria—Niacin—coronary artery disease	0.00016	0.00163	CcSEcCtD
Probenecid—Decreased appetite—Captopril—coronary artery disease	0.00016	0.00163	CcSEcCtD
Probenecid—Anorexia—Losartan—coronary artery disease	0.00016	0.00163	CcSEcCtD
Probenecid—Nausea—Acetylsalicylic acid—coronary artery disease	0.00016	0.00163	CcSEcCtD
Probenecid—Pruritus—Eplerenone—coronary artery disease	0.00016	0.00163	CcSEcCtD
Probenecid—Body temperature increased—Niacin—coronary artery disease	0.00016	0.00163	CcSEcCtD
Probenecid—Dizziness—Fenofibrate—coronary artery disease	0.000159	0.00162	CcSEcCtD
Probenecid—Leukopenia—Ramipril—coronary artery disease	0.000158	0.00161	CcSEcCtD
Probenecid—Urticaria—Pravastatin—coronary artery disease	0.000158	0.00161	CcSEcCtD
Probenecid—Body temperature increased—Pravastatin—coronary artery disease	0.000157	0.0016	CcSEcCtD
Probenecid—CYP2C8—blood—coronary artery disease	0.000157	0.00653	CbGeAlD
Probenecid—Dizziness—Clopidogrel—coronary artery disease	0.000156	0.00159	CcSEcCtD
Probenecid—Decreased appetite—Perindopril—coronary artery disease	0.000156	0.00159	CcSEcCtD
Probenecid—Pruritus—Simvastatin—coronary artery disease	0.000156	0.00159	CcSEcCtD
Probenecid—Dizziness—Lovastatin—coronary artery disease	0.000155	0.00158	CcSEcCtD
Probenecid—Urticaria—Trandolapril—coronary artery disease	0.000153	0.00156	CcSEcCtD
Probenecid—Pain—Perindopril—coronary artery disease	0.000153	0.00156	CcSEcCtD
Probenecid—Vomiting—Fenofibrate—coronary artery disease	0.000153	0.00156	CcSEcCtD
Probenecid—Hypersensitivity—Valsartan—coronary artery disease	0.000153	0.00156	CcSEcCtD
Probenecid—Urticaria—Enalapril—coronary artery disease	0.000153	0.00156	CcSEcCtD
Probenecid—Body temperature increased—Trandolapril—coronary artery disease	0.000153	0.00156	CcSEcCtD
Probenecid—Dizziness—Ezetimibe—coronary artery disease	0.000152	0.00155	CcSEcCtD
Probenecid—Body temperature increased—Enalapril—coronary artery disease	0.000152	0.00155	CcSEcCtD
Probenecid—Dermatitis—Fenofibrate—coronary artery disease	0.000152	0.00155	CcSEcCtD
Probenecid—Decreased appetite—Furosemide—coronary artery disease	0.000151	0.00154	CcSEcCtD
Probenecid—Headache—Fenofibrate—coronary artery disease	0.000151	0.00154	CcSEcCtD
Probenecid—Urticaria—Telmisartan—coronary artery disease	0.000151	0.00154	CcSEcCtD
Probenecid—Vomiting—Clopidogrel—coronary artery disease	0.00015	0.00153	CcSEcCtD
Probenecid—Body temperature increased—Telmisartan—coronary artery disease	0.00015	0.00153	CcSEcCtD
Probenecid—Vomiting—Lovastatin—coronary artery disease	0.000149	0.00152	CcSEcCtD
Probenecid—Dizziness—Eplerenone—coronary artery disease	0.000149	0.00152	CcSEcCtD
Probenecid—Dermatitis—Clopidogrel—coronary artery disease	0.000149	0.00152	CcSEcCtD
Probenecid—Pain—Furosemide—coronary artery disease	0.000149	0.00152	CcSEcCtD
Probenecid—Hypersensitivity—Niacin—coronary artery disease	0.000149	0.00152	CcSEcCtD
Probenecid—Headache—Clopidogrel—coronary artery disease	0.000148	0.00151	CcSEcCtD
Probenecid—Dermatitis—Lovastatin—coronary artery disease	0.000148	0.00151	CcSEcCtD
Probenecid—Anaemia—Lisinopril—coronary artery disease	0.000148	0.00151	CcSEcCtD
Probenecid—Headache—Lovastatin—coronary artery disease	0.000147	0.0015	CcSEcCtD
Probenecid—Pruritus—Valsartan—coronary artery disease	0.000147	0.0015	CcSEcCtD
Probenecid—Vomiting—Ezetimibe—coronary artery disease	0.000147	0.00149	CcSEcCtD
Probenecid—Hypersensitivity—Pravastatin—coronary artery disease	0.000146	0.00149	CcSEcCtD
Probenecid—Pruritus—Olmesartan—coronary artery disease	0.000146	0.00149	CcSEcCtD
Probenecid—Decreased appetite—Losartan—coronary artery disease	0.000146	0.00149	CcSEcCtD
Probenecid—Body temperature increased—Captopril—coronary artery disease	0.000146	0.00149	CcSEcCtD
Probenecid—Dizziness—Simvastatin—coronary artery disease	0.000145	0.00148	CcSEcCtD
Probenecid—Dermatitis—Ezetimibe—coronary artery disease	0.000145	0.00148	CcSEcCtD
Probenecid—Headache—Ezetimibe—coronary artery disease	0.000144	0.00147	CcSEcCtD
Probenecid—Anaphylactic shock—Ramipril—coronary artery disease	0.000144	0.00147	CcSEcCtD
Probenecid—Pain—Losartan—coronary artery disease	0.000144	0.00146	CcSEcCtD
Probenecid—Vomiting—Eplerenone—coronary artery disease	0.000143	0.00146	CcSEcCtD
Probenecid—Leukopenia—Lisinopril—coronary artery disease	0.000143	0.00146	CcSEcCtD
Probenecid—Nausea—Fenofibrate—coronary artery disease	0.000143	0.00146	CcSEcCtD
Probenecid—Pruritus—Niacin—coronary artery disease	0.000143	0.00146	CcSEcCtD
Probenecid—Urticaria—Perindopril—coronary artery disease	0.000142	0.00145	CcSEcCtD
Probenecid—Hypersensitivity—Trandolapril—coronary artery disease	0.000142	0.00145	CcSEcCtD
Probenecid—Dermatitis—Eplerenone—coronary artery disease	0.000142	0.00145	CcSEcCtD
Probenecid—Hypersensitivity—Enalapril—coronary artery disease	0.000142	0.00144	CcSEcCtD
Probenecid—Body temperature increased—Perindopril—coronary artery disease	0.000142	0.00144	CcSEcCtD
Probenecid—Headache—Eplerenone—coronary artery disease	0.000141	0.00144	CcSEcCtD
Probenecid—Anaphylactic shock—Timolol—coronary artery disease	0.000141	0.00143	CcSEcCtD
Probenecid—Pruritus—Pravastatin—coronary artery disease	0.000141	0.00143	CcSEcCtD
Probenecid—Nausea—Clopidogrel—coronary artery disease	0.000141	0.00143	CcSEcCtD
Probenecid—Vomiting—Simvastatin—coronary artery disease	0.00014	0.00142	CcSEcCtD
Probenecid—Hypersensitivity—Telmisartan—coronary artery disease	0.00014	0.00142	CcSEcCtD
Probenecid—Nausea—Lovastatin—coronary artery disease	0.00014	0.00142	CcSEcCtD
Probenecid—CYP2C9—blood—coronary artery disease	0.000139	0.0058	CbGeAlD
Probenecid—Dermatitis—Simvastatin—coronary artery disease	0.000139	0.00141	CcSEcCtD
Probenecid—Urticaria—Furosemide—coronary artery disease	0.000138	0.00141	CcSEcCtD
Probenecid—Headache—Simvastatin—coronary artery disease	0.000138	0.0014	CcSEcCtD
Probenecid—Body temperature increased—Furosemide—coronary artery disease	0.000138	0.0014	CcSEcCtD
Probenecid—Dizziness—Valsartan—coronary artery disease	0.000137	0.0014	CcSEcCtD
Probenecid—Anorexia—Ramipril—coronary artery disease	0.000137	0.0014	CcSEcCtD
Probenecid—Nausea—Ezetimibe—coronary artery disease	0.000137	0.0014	CcSEcCtD
Probenecid—Dizziness—Olmesartan—coronary artery disease	0.000137	0.00139	CcSEcCtD
Probenecid—Pruritus—Trandolapril—coronary artery disease	0.000137	0.00139	CcSEcCtD
Probenecid—Pruritus—Enalapril—coronary artery disease	0.000136	0.00139	CcSEcCtD
Probenecid—Anorexia—Timolol—coronary artery disease	0.000134	0.00137	CcSEcCtD
Probenecid—Pruritus—Telmisartan—coronary artery disease	0.000134	0.00137	CcSEcCtD
Probenecid—Nausea—Eplerenone—coronary artery disease	0.000134	0.00137	CcSEcCtD
Probenecid—Dizziness—Niacin—coronary artery disease	0.000134	0.00136	CcSEcCtD
Probenecid—Urticaria—Losartan—coronary artery disease	0.000133	0.00136	CcSEcCtD
Probenecid—Body temperature increased—Losartan—coronary artery disease	0.000133	0.00135	CcSEcCtD
Probenecid—Vomiting—Valsartan—coronary artery disease	0.000132	0.00135	CcSEcCtD
Probenecid—Dizziness—Pravastatin—coronary artery disease	0.000131	0.00134	CcSEcCtD
Probenecid—Vomiting—Olmesartan—coronary artery disease	0.000131	0.00134	CcSEcCtD
Probenecid—Dermatitis—Valsartan—coronary artery disease	0.000131	0.00133	CcSEcCtD
Probenecid—Nausea—Simvastatin—coronary artery disease	0.000131	0.00133	CcSEcCtD
Probenecid—Anaphylactic shock—Lisinopril—coronary artery disease	0.000131	0.00133	CcSEcCtD
Probenecid—Pruritus—Captopril—coronary artery disease	0.00013	0.00133	CcSEcCtD
Probenecid—Dermatitis—Olmesartan—coronary artery disease	0.00013	0.00133	CcSEcCtD
Probenecid—Headache—Valsartan—coronary artery disease	0.00013	0.00133	CcSEcCtD
Probenecid—Headache—Olmesartan—coronary artery disease	0.000129	0.00132	CcSEcCtD
Probenecid—Vomiting—Niacin—coronary artery disease	0.000128	0.00131	CcSEcCtD
Probenecid—Hypersensitivity—Furosemide—coronary artery disease	0.000128	0.00131	CcSEcCtD
Probenecid—Dizziness—Trandolapril—coronary artery disease	0.000128	0.0013	CcSEcCtD
Probenecid—Dermatitis—Niacin—coronary artery disease	0.000127	0.0013	CcSEcCtD
Probenecid—Dizziness—Enalapril—coronary artery disease	0.000127	0.0013	CcSEcCtD
Probenecid—Pruritus—Perindopril—coronary artery disease	0.000127	0.00129	CcSEcCtD
Probenecid—Headache—Niacin—coronary artery disease	0.000126	0.00129	CcSEcCtD
Probenecid—Vomiting—Pravastatin—coronary artery disease	0.000126	0.00129	CcSEcCtD
Probenecid—Dizziness—Telmisartan—coronary artery disease	0.000125	0.00128	CcSEcCtD
Probenecid—Dermatitis—Pravastatin—coronary artery disease	0.000125	0.00128	CcSEcCtD
Probenecid—Decreased appetite—Ramipril—coronary artery disease	0.000125	0.00128	CcSEcCtD
Probenecid—Headache—Pravastatin—coronary artery disease	0.000125	0.00127	CcSEcCtD
Probenecid—Anorexia—Lisinopril—coronary artery disease	0.000124	0.00127	CcSEcCtD
Probenecid—Hypersensitivity—Losartan—coronary artery disease	0.000124	0.00126	CcSEcCtD
Probenecid—Nausea—Valsartan—coronary artery disease	0.000123	0.00126	CcSEcCtD
Probenecid—Pruritus—Furosemide—coronary artery disease	0.000123	0.00125	CcSEcCtD
Probenecid—Nausea—Olmesartan—coronary artery disease	0.000123	0.00125	CcSEcCtD
Probenecid—Vomiting—Trandolapril—coronary artery disease	0.000123	0.00125	CcSEcCtD
Probenecid—Decreased appetite—Timolol—coronary artery disease	0.000122	0.00125	CcSEcCtD
Probenecid—Vomiting—Enalapril—coronary artery disease	0.000122	0.00125	CcSEcCtD
Probenecid—Dizziness—Captopril—coronary artery disease	0.000122	0.00124	CcSEcCtD
Probenecid—Dermatitis—Trandolapril—coronary artery disease	0.000122	0.00124	CcSEcCtD
Probenecid—Dermatitis—Enalapril—coronary artery disease	0.000121	0.00123	CcSEcCtD
Probenecid—Headache—Trandolapril—coronary artery disease	0.000121	0.00123	CcSEcCtD
Probenecid—Vomiting—Telmisartan—coronary artery disease	0.000121	0.00123	CcSEcCtD
Probenecid—Headache—Enalapril—coronary artery disease	0.00012	0.00123	CcSEcCtD
Probenecid—Pain—Timolol—coronary artery disease	0.00012	0.00123	CcSEcCtD
Probenecid—Nausea—Niacin—coronary artery disease	0.00012	0.00122	CcSEcCtD
Probenecid—Dermatitis—Telmisartan—coronary artery disease	0.000119	0.00122	CcSEcCtD
Probenecid—Pruritus—Losartan—coronary artery disease	0.000119	0.00121	CcSEcCtD
Probenecid—Headache—Telmisartan—coronary artery disease	0.000119	0.00121	CcSEcCtD
Probenecid—Dizziness—Perindopril—coronary artery disease	0.000118	0.00121	CcSEcCtD
Probenecid—Nausea—Pravastatin—coronary artery disease	0.000118	0.0012	CcSEcCtD
Probenecid—Vomiting—Captopril—coronary artery disease	0.000117	0.00119	CcSEcCtD
Probenecid—Dermatitis—Captopril—coronary artery disease	0.000116	0.00118	CcSEcCtD
Probenecid—Headache—Captopril—coronary artery disease	0.000116	0.00118	CcSEcCtD
Probenecid—Dizziness—Furosemide—coronary artery disease	0.000115	0.00117	CcSEcCtD
Probenecid—Nausea—Trandolapril—coronary artery disease	0.000115	0.00117	CcSEcCtD
Probenecid—Urticaria—Ramipril—coronary artery disease	0.000114	0.00117	CcSEcCtD
Probenecid—Nausea—Enalapril—coronary artery disease	0.000114	0.00116	CcSEcCtD
Probenecid—Vomiting—Perindopril—coronary artery disease	0.000114	0.00116	CcSEcCtD
Probenecid—Body temperature increased—Ramipril—coronary artery disease	0.000114	0.00116	CcSEcCtD
Probenecid—Decreased appetite—Lisinopril—coronary artery disease	0.000114	0.00116	CcSEcCtD
Probenecid—Dermatitis—Perindopril—coronary artery disease	0.000113	0.00115	CcSEcCtD
Probenecid—Nausea—Telmisartan—coronary artery disease	0.000113	0.00115	CcSEcCtD
Probenecid—Headache—Perindopril—coronary artery disease	0.000112	0.00114	CcSEcCtD
Probenecid—Urticaria—Timolol—coronary artery disease	0.000112	0.00114	CcSEcCtD
Probenecid—Pain—Lisinopril—coronary artery disease	0.000112	0.00114	CcSEcCtD
Probenecid—Body temperature increased—Timolol—coronary artery disease	0.000111	0.00113	CcSEcCtD
Probenecid—Dizziness—Losartan—coronary artery disease	0.000111	0.00113	CcSEcCtD
Probenecid—Vomiting—Furosemide—coronary artery disease	0.000111	0.00113	CcSEcCtD
Probenecid—Dermatitis—Furosemide—coronary artery disease	0.00011	0.00112	CcSEcCtD
Probenecid—Nausea—Captopril—coronary artery disease	0.00011	0.00112	CcSEcCtD
Probenecid—Headache—Furosemide—coronary artery disease	0.000109	0.00111	CcSEcCtD
Probenecid—Vomiting—Losartan—coronary artery disease	0.000107	0.00109	CcSEcCtD
Probenecid—Nausea—Perindopril—coronary artery disease	0.000106	0.00108	CcSEcCtD
Probenecid—Hypersensitivity—Ramipril—coronary artery disease	0.000106	0.00108	CcSEcCtD
Probenecid—CYP3A4—blood—coronary artery disease	0.000106	0.00443	CbGeAlD
Probenecid—Dermatitis—Losartan—coronary artery disease	0.000106	0.00108	CcSEcCtD
Probenecid—Headache—Losartan—coronary artery disease	0.000105	0.00107	CcSEcCtD
Probenecid—Urticaria—Lisinopril—coronary artery disease	0.000104	0.00106	CcSEcCtD
Probenecid—Hypersensitivity—Timolol—coronary artery disease	0.000104	0.00106	CcSEcCtD
Probenecid—Nausea—Furosemide—coronary artery disease	0.000103	0.00105	CcSEcCtD
Probenecid—Body temperature increased—Lisinopril—coronary artery disease	0.000103	0.00105	CcSEcCtD
Probenecid—Pruritus—Ramipril—coronary artery disease	0.000102	0.00104	CcSEcCtD
Probenecid—ABCB1—heart—coronary artery disease	0.000101	0.0042	CbGeAlD
Probenecid—Nausea—Losartan—coronary artery disease	9.98e-05	0.00102	CcSEcCtD
Probenecid—Pruritus—Timolol—coronary artery disease	9.96e-05	0.00101	CcSEcCtD
Probenecid—Hypersensitivity—Lisinopril—coronary artery disease	9.62e-05	0.000981	CcSEcCtD
Probenecid—Dizziness—Ramipril—coronary artery disease	9.52e-05	0.00097	CcSEcCtD
Probenecid—ABCB1—cardiovascular system—coronary artery disease	9.49e-05	0.00396	CbGeAlD
Probenecid—Dizziness—Timolol—coronary artery disease	9.31e-05	0.000949	CcSEcCtD
Probenecid—Pruritus—Lisinopril—coronary artery disease	9.24e-05	0.000942	CcSEcCtD
Probenecid—Vomiting—Ramipril—coronary artery disease	9.16e-05	0.000933	CcSEcCtD
Probenecid—Dermatitis—Ramipril—coronary artery disease	9.07e-05	0.000924	CcSEcCtD
Probenecid—Headache—Ramipril—coronary artery disease	9.02e-05	0.000919	CcSEcCtD
Probenecid—Vomiting—Timolol—coronary artery disease	8.95e-05	0.000912	CcSEcCtD
Probenecid—Dermatitis—Timolol—coronary artery disease	8.87e-05	0.000904	CcSEcCtD
Probenecid—Headache—Timolol—coronary artery disease	8.82e-05	0.000899	CcSEcCtD
Probenecid—Dizziness—Lisinopril—coronary artery disease	8.64e-05	0.00088	CcSEcCtD
Probenecid—Nausea—Ramipril—coronary artery disease	8.55e-05	0.000872	CcSEcCtD
Probenecid—Nausea—Timolol—coronary artery disease	8.36e-05	0.000852	CcSEcCtD
Probenecid—Vomiting—Lisinopril—coronary artery disease	8.3e-05	0.000846	CcSEcCtD
Probenecid—Dermatitis—Lisinopril—coronary artery disease	8.23e-05	0.000838	CcSEcCtD
Probenecid—Headache—Lisinopril—coronary artery disease	8.18e-05	0.000834	CcSEcCtD
Probenecid—Nausea—Lisinopril—coronary artery disease	7.76e-05	0.000791	CcSEcCtD
Probenecid—ABCB1—blood—coronary artery disease	7.51e-05	0.00313	CbGeAlD
Probenecid—CYP2C19—Metabolism—HMGCR—coronary artery disease	1.77e-06	1.81e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GOT2—coronary artery disease	1.77e-06	1.81e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ABCA1—coronary artery disease	1.76e-06	1.81e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—SDC1—coronary artery disease	1.76e-06	1.8e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AGT—coronary artery disease	1.76e-06	1.8e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—ABCA1—coronary artery disease	1.75e-06	1.8e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.75e-06	1.79e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.75e-06	1.79e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CTGF—coronary artery disease	1.74e-06	1.78e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PTGS2—coronary artery disease	1.74e-06	1.78e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOE—coronary artery disease	1.73e-06	1.77e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GOT2—coronary artery disease	1.73e-06	1.77e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMGCR—coronary artery disease	1.73e-06	1.77e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.72e-06	1.76e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GOT1—coronary artery disease	1.71e-06	1.75e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GGT1—coronary artery disease	1.71e-06	1.75e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—APOA1—coronary artery disease	1.71e-06	1.75e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GOT1—coronary artery disease	1.7e-06	1.74e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GGT1—coronary artery disease	1.7e-06	1.74e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.7e-06	1.74e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HADH—coronary artery disease	1.7e-06	1.74e-05	CbGpPWpGaD
Probenecid—ABCB1—Transmembrane transport of small molecules—ALB—coronary artery disease	1.69e-06	1.73e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—ALB—coronary artery disease	1.66e-06	1.7e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.66e-06	1.7e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.66e-06	1.7e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.66e-06	1.7e-05	CbGpPWpGaD
Probenecid—SLC10A1—Metabolism—AKT1—coronary artery disease	1.65e-06	1.69e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—IL6—coronary artery disease	1.64e-06	1.68e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CTGF—coronary artery disease	1.63e-06	1.66e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PLCB1—coronary artery disease	1.63e-06	1.66e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PTGS2—coronary artery disease	1.62e-06	1.66e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PPARG—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GOT2—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOA2—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX2—coronary artery disease	1.61e-06	1.65e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—NOS3—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—POMC—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX4—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HK1—coronary artery disease	1.59e-06	1.63e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PLCB1—coronary artery disease	1.59e-06	1.62e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ABCA1—coronary artery disease	1.58e-06	1.61e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HADHA—coronary artery disease	1.57e-06	1.61e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—PIK3CA—coronary artery disease	1.55e-06	1.59e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.55e-06	1.59e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ABCA1—coronary artery disease	1.54e-06	1.57e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—VEGFA—coronary artery disease	1.54e-06	1.57e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTP1—coronary artery disease	1.54e-06	1.57e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LPA—coronary artery disease	1.53e-06	1.57e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTP1—coronary artery disease	1.53e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GGT1—coronary artery disease	1.53e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GOT1—coronary artery disease	1.53e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARGC1A—coronary artery disease	1.52e-06	1.56e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—HMOX1—coronary artery disease	1.51e-06	1.55e-05	CbGpPWpGaD
Probenecid—ABCC5—Disease—AKT1—coronary artery disease	1.51e-06	1.55e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARGC1A—coronary artery disease	1.51e-06	1.55e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—HMOX1—coronary artery disease	1.51e-06	1.54e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PPARG—coronary artery disease	1.5e-06	1.54e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CAT—coronary artery disease	1.49e-06	1.53e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GGT1—coronary artery disease	1.49e-06	1.52e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GOT1—coronary artery disease	1.49e-06	1.52e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CAT—coronary artery disease	1.49e-06	1.52e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.48e-06	1.52e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—POMC—coronary artery disease	1.48e-06	1.52e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.48e-06	1.52e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOA5—coronary artery disease	1.47e-06	1.5e-05	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PTGS2—coronary artery disease	1.46e-06	1.49e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.45e-06	1.49e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOB—coronary artery disease	1.45e-06	1.48e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—ALB—coronary artery disease	1.45e-06	1.48e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—PIK3CA—coronary artery disease	1.44e-06	1.48e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOB—coronary artery disease	1.44e-06	1.48e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—P4HB—coronary artery disease	1.44e-06	1.48e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.44e-06	1.47e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.42e-06	1.45e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GSTM1—coronary artery disease	1.41e-06	1.44e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—TGFB1—coronary artery disease	1.41e-06	1.44e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GSTM1—coronary artery disease	1.4e-06	1.44e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GOT1—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GGT1—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—NOS3—coronary artery disease	1.39e-06	1.42e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—LPL—coronary artery disease	1.38e-06	1.42e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—MAPK1—coronary artery disease	1.38e-06	1.42e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—LPL—coronary artery disease	1.38e-06	1.41e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTP1—coronary artery disease	1.37e-06	1.4e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARGC1A—coronary artery disease	1.36e-06	1.39e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—HMOX1—coronary artery disease	1.35e-06	1.38e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—ALB—coronary artery disease	1.35e-06	1.38e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—GPX1—coronary artery disease	1.35e-06	1.38e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—GPX1—coronary artery disease	1.34e-06	1.38e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTP1—coronary artery disease	1.34e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—VCAN—coronary artery disease	1.33e-06	1.37e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CAT—coronary artery disease	1.33e-06	1.36e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARGC1A—coronary artery disease	1.33e-06	1.36e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.32e-06	1.35e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—HMOX1—coronary artery disease	1.32e-06	1.35e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—CD36—coronary artery disease	1.32e-06	1.35e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—CD36—coronary artery disease	1.31e-06	1.34e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CAT—coronary artery disease	1.3e-06	1.33e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPP2CA—coronary artery disease	1.3e-06	1.33e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOB—coronary artery disease	1.29e-06	1.33e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—NOS3—coronary artery disease	1.29e-06	1.32e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPP2CA—coronary artery disease	1.29e-06	1.32e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—DCN—coronary artery disease	1.28e-06	1.32e-05	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PTGS2—coronary artery disease	1.27e-06	1.3e-05	CbGpPWpGaD
Probenecid—ABCC5—Metabolism—AKT1—coronary artery disease	1.27e-06	1.3e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOB—coronary artery disease	1.26e-06	1.29e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GSTM1—coronary artery disease	1.26e-06	1.29e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—TGFB1—coronary artery disease	1.26e-06	1.29e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.25e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.25e-06	1.28e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—MTHFR—coronary artery disease	1.25e-06	1.28e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—MTHFR—coronary artery disease	1.24e-06	1.27e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.24e-06	1.27e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—LPL—coronary artery disease	1.24e-06	1.27e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—MAPK1—coronary artery disease	1.23e-06	1.26e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.23e-06	1.26e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GSTM1—coronary artery disease	1.23e-06	1.26e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HBA1—coronary artery disease	1.22e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LIPC—coronary artery disease	1.22e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.22e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.22e-06	1.25e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CAT—coronary artery disease	1.22e-06	1.24e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOC3—coronary artery disease	1.21e-06	1.24e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—LPL—coronary artery disease	1.21e-06	1.23e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—GPX1—coronary artery disease	1.21e-06	1.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LDLR—coronary artery disease	1.2e-06	1.23e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—PIK3CA—coronary artery disease	1.2e-06	1.23e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.19e-06	1.22e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.19e-06	1.22e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AGT—coronary artery disease	1.18e-06	1.21e-05	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PTGS2—coronary artery disease	1.18e-06	1.21e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOB—coronary artery disease	1.18e-06	1.21e-05	CbGpPWpGaD
Probenecid—SLC16A1—Metabolism—AKT1—coronary artery disease	1.18e-06	1.21e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—AGT—coronary artery disease	1.18e-06	1.21e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—GPX1—coronary artery disease	1.18e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GCLC—coronary artery disease	1.18e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CETP—coronary artery disease	1.18e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—CD36—coronary artery disease	1.17e-06	1.2e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—SDC1—coronary artery disease	1.16e-06	1.19e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOE—coronary artery disease	1.16e-06	1.19e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPP2CA—coronary artery disease	1.16e-06	1.19e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOE—coronary artery disease	1.15e-06	1.18e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GSTM1—coronary artery disease	1.15e-06	1.18e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—APOA1—coronary artery disease	1.15e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—CD36—coronary artery disease	1.15e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—PIK3CA—coronary artery disease	1.14e-06	1.17e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—APOA1—coronary artery disease	1.14e-06	1.17e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPP2CA—coronary artery disease	1.13e-06	1.16e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—LPL—coronary artery disease	1.13e-06	1.15e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—MTHFR—coronary artery disease	1.11e-06	1.14e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—GPX1—coronary artery disease	1.1e-06	1.13e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.1e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.1e-06	1.12e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.1e-06	1.12e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.09e-06	1.12e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—MTHFR—coronary artery disease	1.09e-06	1.11e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CTGF—coronary artery disease	1.07e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—CD36—coronary artery disease	1.07e-06	1.1e-05	CbGpPWpGaD
Probenecid—ABCC1—Disease—PIK3CA—coronary artery disease	1.07e-06	1.1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GOT2—coronary artery disease	1.06e-06	1.09e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.06e-06	1.09e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPP2CA—coronary artery disease	1.06e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AGT—coronary artery disease	1.06e-06	1.08e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOE—coronary artery disease	1.04e-06	1.06e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AGT—coronary artery disease	1.03e-06	1.06e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—APOA1—coronary artery disease	1.02e-06	1.05e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—MTHFR—coronary artery disease	1.01e-06	1.04e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOE—coronary artery disease	1.01e-06	1.04e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PPARG—coronary artery disease	1.01e-06	1.03e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—PPARG—coronary artery disease	1.01e-06	1.03e-05	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—APOA1—coronary artery disease	1e-06	1.02e-05	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—POMC—coronary artery disease	9.97e-07	1.02e-05	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—PIK3CA—coronary artery disease	9.96e-07	1.02e-05	CbGpPWpGaD
Probenecid—ALB—Metabolism—POMC—coronary artery disease	9.92e-07	1.01e-05	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	9.81e-07	1e-05	CbGpPWpGaD
Probenecid—ALB—Hemostasis—AKT1—coronary artery disease	9.8e-07	1e-05	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PLCB1—coronary artery disease	9.77e-07	1e-05	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AGT—coronary artery disease	9.64e-07	9.87e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—IL6—coronary artery disease	9.48e-07	9.7e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ABCA1—coronary artery disease	9.47e-07	9.7e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOE—coronary artery disease	9.45e-07	9.67e-06	CbGpPWpGaD
Probenecid—ABCC3—Metabolism—AKT1—coronary artery disease	9.34e-07	9.56e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—APOA1—coronary artery disease	9.34e-07	9.56e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GGT1—coronary artery disease	9.17e-07	9.39e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GOT1—coronary artery disease	9.17e-07	9.39e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—ALB—coronary artery disease	9.09e-07	9.31e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PPARG—coronary artery disease	9.03e-07	9.24e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—PIK3CA—coronary artery disease	8.96e-07	9.17e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	8.94e-07	9.15e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—POMC—coronary artery disease	8.9e-07	9.11e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PPARG—coronary artery disease	8.81e-07	9.02e-06	CbGpPWpGaD
Probenecid—ABCC1—Disease—AKT1—coronary artery disease	8.74e-07	8.95e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—NOS3—coronary artery disease	8.7e-07	8.9e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—POMC—coronary artery disease	8.69e-07	8.89e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—NOS3—coronary artery disease	8.65e-07	8.85e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.24e-07	8.44e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PPARG—coronary artery disease	8.23e-07	8.42e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	8.16e-07	8.36e-06	CbGpPWpGaD
Probenecid—SLCO1A2—Metabolism—AKT1—coronary artery disease	8.14e-07	8.33e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—HMOX1—coronary artery disease	8.13e-07	8.32e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—POMC—coronary artery disease	8.12e-07	8.31e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—ALB—coronary artery disease	8.12e-07	8.31e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CAT—coronary artery disease	8.02e-07	8.21e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PTGS2—coronary artery disease	7.95e-07	8.14e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—ALB—coronary artery disease	7.92e-07	8.11e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PTGS2—coronary artery disease	7.91e-07	8.1e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—PIK3CA—coronary artery disease	7.8e-07	7.99e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOB—coronary artery disease	7.78e-07	7.97e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—NOS3—coronary artery disease	7.76e-07	7.95e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—NOS3—coronary artery disease	7.58e-07	7.76e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.57e-07	7.75e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—LPL—coronary artery disease	7.43e-07	7.61e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—ALB—coronary artery disease	7.4e-07	7.57e-06	CbGpPWpGaD
Probenecid—ABCC1—Metabolism—AKT1—coronary artery disease	7.32e-07	7.49e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—PIK3CA—coronary artery disease	7.27e-07	7.45e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—GPX1—coronary artery disease	7.25e-07	7.42e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PTGS2—coronary artery disease	7.1e-07	7.27e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—NOS3—coronary artery disease	7.08e-07	7.24e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—CD36—coronary artery disease	7.06e-07	7.23e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.97e-07	7.14e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PTGS2—coronary artery disease	6.93e-07	7.09e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.69e-07	6.85e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PTGS2—coronary artery disease	6.47e-07	6.63e-06	CbGpPWpGaD
Probenecid—SLC22A2—Metabolism—AKT1—coronary artery disease	6.38e-07	6.53e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AGT—coronary artery disease	6.36e-07	6.51e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOE—coronary artery disease	6.23e-07	6.38e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—APOA1—coronary artery disease	6.16e-07	6.3e-06	CbGpPWpGaD
Probenecid—SLC22A1—Metabolism—AKT1—coronary artery disease	5.94e-07	6.08e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PPARG—coronary artery disease	5.43e-07	5.56e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—POMC—coronary artery disease	5.35e-07	5.48e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—PIK3CA—coronary artery disease	4.89e-07	5.01e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—ALB—coronary artery disease	4.88e-07	5e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—PIK3CA—coronary artery disease	4.87e-07	4.98e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—NOS3—coronary artery disease	4.67e-07	4.78e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—PIK3CA—coronary artery disease	4.37e-07	4.47e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.27e-07	4.37e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—PIK3CA—coronary artery disease	4.26e-07	4.36e-06	CbGpPWpGaD
Probenecid—CYP2C8—Metabolism—AKT1—coronary artery disease	4e-07	4.09e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.98e-07	4.08e-06	CbGpPWpGaD
Probenecid—ALB—Metabolism—AKT1—coronary artery disease	3.97e-07	4.07e-06	CbGpPWpGaD
Probenecid—CYP2C19—Metabolism—AKT1—coronary artery disease	3.57e-07	3.65e-06	CbGpPWpGaD
Probenecid—ABCB1—Metabolism—AKT1—coronary artery disease	3.48e-07	3.56e-06	CbGpPWpGaD
Probenecid—CYP2C9—Metabolism—AKT1—coronary artery disease	3.25e-07	3.33e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.63e-07	2.69e-06	CbGpPWpGaD
Probenecid—CYP3A4—Metabolism—AKT1—coronary artery disease	2.15e-07	2.2e-06	CbGpPWpGaD
